Biogen (Comparative Multiple Analysis)

Home Comparative Index Biogen

►Summary | Profile | News | Chart | SWOT | Cash Flow | Comps | Buffett | WACC

Link to services page Summary | Profile | SWOT | Cash Flow | Comps | Buffett | WACC Improve your investment analysis with by seeing the Biogen's Discounted Cash Flow analysis, Biogen's Warren Buffet analysis, and Biogen's Weighted Average Cost of Capital (WACC) Analysis. Notes on the Comparative Multiple Analysis of Biogen WikiWealth compares Biogen's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Biogen's comparative analysis. Notes from the analysis: 1. WikiWealth uses quantitative measures to determine the multiple range for Biogen. 2. Free cash flow to the firm (FCF) multiple is free cash flow to equity holders plus interest owed to Biogen's debt holders. 3. Multiples incorporate benefits due to economies of scale; WikiWealth compares absolute enterprise value multiples to competitor's multiples. 4. WikiWealth excludes outliers when calculating individual company multiples. Helpful Information for Biogen's Analysis How does this work? The Comparative Investment Analysis determines the value of Biogen by comparing Biogen financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups. Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Biogen. See the Biogen cash flow (DCF) analysis for a completely different approach that's popular on Wall Street for determining the value of an investment in Biogen. Also, see the Biogen's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Biogen's valuation conclusion for a quick summary.